lysophosphatidic acid has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevalier, E; Dembowsky, K; Hamesch, K; Li, X; Schober, A; Subramanian, P; Weber, C | 1 |
| Cohn, HI; Eckhart, AD; Pesant, S; Zhou, RH | 1 |
2 other study(ies) available for lysophosphatidic acid and Coronary Restenosis
| Article | Year |
|---|---|
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.
Topics: Angioplasty; Animals; Apolipoproteins E; Blood Vessel Prosthesis Implantation; Carotid Arteries; Cell Movement; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Humans; Lysophospholipids; Macrophages; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Neointima; Postoperative Complications; Proteins; Receptors, CXCR4; Sirolimus | 2012 |
Enhanced sterol response element-binding protein in postintervention restenotic blood vessels plays an important role in vascular smooth muscle proliferation.
Topics: Animals; Aorta, Abdominal; Biomarkers; Blood Vessels; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylephrine; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; RNA, Small Interfering; Stents; Sterol Regulatory Element Binding Protein 1 | 2008 |